Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes. Foster TP, Jacobsen LM, Bruggeman B, Salmon C, et al. Diabetes Care 2023 Dec 20:dc231750. doi: 10.2337/dc23-1750.

Read + Share

Amedeo Smart

Independent Medical Education

Foster TP, Jacobsen LM, Bruggeman B, Salmon C, et al. Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes. Diabetes Care 2023 Dec 20:dc231750. doi: 10.2337/dc23-1750.
PMID: 38117469